Merck & Co Inc

NYSE: MRK
$99.85
-$1.17 (-1.2%)
Closing Price on January 8, 2025

MRK Articles

The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.
The Dow Jones Industrial Average closed essentially flat on Friday, with Nike and Merck posting the largest losses and Goldman Sachs and Cisco Systems putting up the biggest gains.
The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Apple, UnitedHealth, Walmart, and Merck led the losers among the Dow 30 stocks on Friday.
United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.
Although the markets were mixed on Thursday, major drug manufacturers proved to be one of the more positive segments on the day.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped.
The Commerce Department reports that more than 15 million jobs could be affected by self-driving cars, many major hedge funds have sold shares of Apple and Facebook, and more headlines.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Merck, Johnson & Johnson, DuPont, and Verizon led the 20 stocks that were heading for a lower close just minutes before the closing bell.
Verizon, Boeing, Merck, and Disney were Thursday's leading DJIA gainers.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.